Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01324713 · ClinicalTrials.gov registry record
Does Gender Play a Role in Bone-mineral Density Measurement Precision?
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 180
- Enrollment target
NCT01324713 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 180 participants.
The verdict
NCT01324713 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 180 participants
- Enrollment target
Study Summary
Bone mineral density (BMD) measurement using dual-energy x-ray absorptiometry (DXA) is the current gold standard for osteoporosis diagnosis and therapy monitoring. Like all quantitative tests, there is some variability in BMD results obtained when scanning a person more than once. As such, it is current clinical practice, based on the recommendation of the International Society for Clinical Densitometry, that each technologist perform a precision assessment. This approach consists of scanning 30 people twice; the data from which allow determination of what constitutes a real difference in BMD with 95% confidence. A precision assessment typically evaluates a specific clinic's population, using the age range and genders seen at that clinic. However men generally have larger, but often more arthritic, bones than women which may impact the precision results. Therefore, it is possible that gender-specific precision values should be used in clinical practice, however this issue has never been investigated.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01324713
The ClinicalTrials.gov registry entry for NCT01324713 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01324713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01324713 about?
NCT01324713 is a clinical study titled "Does Gender Play a Role in Bone-mineral Density Measurement Precision?". Bone mineral density (BMD) measurement using dual-energy x-ray absorptiometry (DXA) is the current gold standard for osteoporosis diagnosis and therapy monitoring. Like all quantitative tests, there is some variability in BMD results obtained when scanning a person more than once. As such, it is cur...
What is the current status of trial NCT01324713?
This trial is currently completed. The enrollment target is 180 participants. The study started on 2010-07. Estimated completion is 2011-01.
Who is sponsoring clinical trial NCT01324713?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.